logo-loader
viewCello Health PLC

Cello Health Plc makes strong start to 2019 with good order book and new wins

Cello Health PLC (LON:CLL) chief executive Mark Scott discusses with Proactive London the group's results for the year to December 2018.

Cello Health's begun 2019 with good levels of forward bookings and has already landed a number of new business wins.

In 2018 the company reported headline profit before tax of £12.2mln, up 6.4% from the £11.4mln reported for 2017.

The group enjoyed strong cash flows in the second half of the year and ended 2018 with net funds of £6.3mln, up from £1.6mln a year earlier.

Quick facts: Cello Health PLC

Price: 130 GBX

AIM:CLL
Market: AIM
Market Cap: £138.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cello Health PLC named herein, including the promotion by the Company of Cello Health PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too. The group delivered net revenue of £54.5mln for the first six months of the year,...

on 18/9/19

RNS

Total Voting Rights

1 week, 1 day ago

Total Voting Rights

on 7/10/19

Disposal

on 2/10/19

Interim Results

on 18/9/19

Acquisition of ISS

on 16/8/19

2 min read